Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
A deployment safety case for AI-assisted prostate cancer diagnosis
Jia Y. et al, (2025), Computers in Biology and Medicine, 192, 110237 - 110237
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis
Schoenpflug LA. et al, (2025), The Journal of Pathology, 265, 184 - 197
‘Case of the Month’ from the Department of Urology, Oxford University Hospitals, Oxford, UK: stereotactic radiotherapy to the vas deferens for PSMA‐PET CT detected local recurrence 10 years after radical prostatectomy
Bates AS. et al, (2024), BJU International, 134, 377 - 379
Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10‐year single‐centre cohort
Anbarasan T. et al, (2024), BJUI Compass, 5, 948 - 950
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy
Hamdy FC. et al, (2024), European Journal of Nuclear Medicine and Molecular Imaging
Characterising borderline areas in bladder tumour grading with Bayesian graph neural networks
Gao S. et al, (2024), 2024 IEEE International Symposium on Biomedical Imaging (ISBI), 1 - 5
Artificial Intelligence-Based Quality Assessment of Histopathology Whole-Slide Images within a Clinical Workflow: Assessment of ‘PathProfiler’ in a Diagnostic Pathology Setting
Browning L. et al, (2024), Diagnostics, 14, 990 - 990
Analysis of 3D pathology samples using weakly supervised AI
Song AH. et al, (2024), Cell, 187, 2502 - 2520.e17
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.
Figiel S. et al, (2023), Molecular cancer, 22
Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types
Rao SR. et al, (2023), International Journal of Molecular Sciences, 24, 12722 - 12722
Department Wide Validation in Digital Pathology-Experience from an Academic Teaching Hospital Using the UK Royal College of Pathologists' Guidance.
Kelleher M. et al, (2023), Diagnostics (Basel, Switzerland), 13
Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique
Bryant RJ. et al, (2023), BJU International, 131, 694 - 704
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of heterogeneity on genomic signature scoring
Figiel S. et al, (2023), European Urology, 83, S1793 - S1794
Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
Abd Hamid M. et al, (2020), Cancer Immunology Research, 8, 203 - 216
Results from ADVANCE: A phase I/II open-label non-randomised safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 (VTP-800) vaccine in combination with PD-1 checkpoint blockade in metastatic prostate cancer
Tuthill M. et al, (2020), ANNALS OF ONCOLOGY, 31, S543 - S543
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
Li X. et al, (2019), Frontiers in Oncology, 9